/PRNewswire/ The dry eye syndrome drugs market is set to grow by USD 2,159.21 million from 2022 to 2027 progressing at a CAGR of 6.53% during the forecast.
Nine drugs recently added to the growing list of medications in short supply according to the FDA and ASHP. The drugs in shortage include acetylcholine chloride, cefdinir edetate calcium disodium.
/PRNewswire/ The global bronchiectasis drugs market size is estimated to grow by USD 326.01 million from 2022 to 2027, according to Technavio. The market is.